Skip to content

Mechanism and effect of transcutaneous acupoint electrical stimulation on asthenospermia - a multiple-centered randomized controlled trial

Mechanism and effect of transcutaneous acupoint electrical stimulation on asthenospermia - a multiple-centered randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-16008604
Enrollment
Unknown
Registered
2016-06-07
Start date
2016-06-13
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

asthenospermia

Interventions

blank:no intervention
TEAS:2 Hz TEAS

Sponsors

Neuroscience Research Institute, Peking University
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. mild to moderate asthenospermia, PR: 10- 32%; PR+NR 18 years old.

Exclusion criteria

Exclusion criteria: 1. there is a serious congenital testicular and genital dysplasia or deformity; 2. there are clear factors which induce dynfunction of spermatogenesis such as drugs, chemistry, physics, nutrition, surgery, trauma 3. the patients has a serious genetic disease, mental disease, autoimmune disease, drug abuse; with severe diseases of other systems, such as heart failure, serious liver and renal dynfunction (serum transaminase is more than twice of the reference point, creatinine clearance rate is less than or equal to 40 ml / min or renal disease activity period); 4. seminal plasma mutation patients induced by following factors, such as inflammation of the epididymis, seminal vesicle prostate, pH, oxygen, nutrition and metabolism are not conducive to sperm motility and survival or semen white blood cell count is greater than 100 million/ml; 5. using other drugs related to the treatment of patients with asthenospermia in 3 month; 6. the body has a pacemaker or other implantable medical electronic devices; 7. using artificial heart lung, electrocardiogram, microwave therapy equipment, etc at the same time; 8. should not be used in the skin damage.

Design outcomes

Primary

MeasureTime frame
progressive motility rate;

Secondary

MeasureTime frame
sperm vitality;sperm concentration;normal sperm morphology rate;progressive motility rate;

Countries

China

Contacts

Public ContactJisheng Han

Neuroscience Research Institute, Peking University

hanjisheng@bjmu.edu.cn+86 010 82801109

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026